It is up to the federal government to make sure America embraces rapid technological change in a way that is “positive for as many of our citizens as possible,” said Rep. John Delaney (D-MD). In an interview with Cheddar, the Congressman said he doesn’t believe such progress is a threat to the labor market. “Innovation generally creates more jobs than it displaces,” said Delaney. “But the problem is oftentimes the jobs that get created by innovation are not located in the same places where the jobs that were displaced are located.” He pointed out that 80 percent of venture capital in this country goes to just California, New York, and Boston, which means that innovation and job creation is highly concentrated in and around those places. “I think that will continue unless policymakers do things to make sure more of our country has the opportunity to have people invest in their communities and kind of benefit from this innovation.” Delaney founded the A.I. Caucus to do just that. Comprised of lawmakers from both sides of the aisle, the group strives to work with the private sector to come up with policy ideas that can help the country keep up with technological change. “I just want to make sure we don’t leave huge parts of the country behind,” he said.

Share:
More In Politics
Skydio CEO On Russia-US Drone Collision
Adam Bry, co-founder and CEO of drone manufacturer Skydio, joined Cheddar News to discuss the company's latest funding round and the Russia-US drone collision.
Fed Set to Launch Digital Payments System Over the Summer
The Federal Reserve on Wednesday evening said its long-awaited digital payment system, the FedNow Service, will start operating in July. The service is designed to provide a national platform for financial institutions to settle payments in real-time and at lower cost. That could include large banks, payment processors, and the U.S. Treasury.
Long-Used US Abortion Pill Under Threat in Texas Lawsuit
A federal judge in Texas raised questions Wednesday about a Christian group's effort to overturn the decades-old U.S. approval of a leading abortion drug, in a case that could threaten the country's most common method for ending pregnancies.
Load More